168 related articles for article (PubMed ID: 30815835)
1. Prognostic value of phase analysis on gated single photon emission computed tomography in patients with cardiac sarcoidosis.
Koyanagawa K; Naya M; Aikawa T; Manabe O; Kuzume M; Ohira H; Tsujino I; Tamaki N; Anzai T
J Nucl Cardiol; 2021 Feb; 28(1):128-136. PubMed ID: 30815835
[TBL] [Abstract][Full Text] [Related]
2. The rate of myocardial perfusion recovery after steroid therapy and its implication for cardiac events in cardiac sarcoidosis and primarily preserved left ventricular ejection fraction.
Koyanagawa K; Naya M; Aikawa T; Manabe O; Furuya S; Kuzume M; Oyama-Manabe N; Ohira H; Tsujino I; Anzai T
J Nucl Cardiol; 2021 Aug; 28(4):1745-1756. PubMed ID: 31605274
[TBL] [Abstract][Full Text] [Related]
3. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
4. Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET.
Yamamoto A; Nagao M; Watanabe E; Imamura Y; Suzuki A; Fukushima K; Ando K; Nakao R; Sakai A; Momose M; Sakai S; Hagiwara N
J Nucl Cardiol; 2021 Jun; 28(3):919-929. PubMed ID: 33728571
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
[TBL] [Abstract][Full Text] [Related]
6. Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis.
Kruse MJ; Kovell L; Kasper EK; Pomper MG; Moller DR; Solnes L; Chen ES; Schindler TH
JACC Cardiovasc Imaging; 2017 Feb; 10(2):157-167. PubMed ID: 28109920
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
Ahmed AI; Abebe AT; Han Y; Alnabelsi T; Agrawal T; Kassi M; Aljizeeri A; Taylor A; Tleyjeh IM; Al-Mallah MH
J Nucl Cardiol; 2021 Aug; 28(4):1545-1552. PubMed ID: 34228337
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular mechanical dyssynchrony analzyed by Tc-99m sestamibi SPECT and F-18 FDG PET in patients with ischemic cardiomyopathy and the prognostic value.
Tian Y; Zhao M; Li W; Zhu Z; Mi H; Li X; Zhang X
Int J Cardiovasc Imaging; 2020 Oct; 36(10):2063-2071. PubMed ID: 32495064
[TBL] [Abstract][Full Text] [Related]
9. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of 231 patients.
Schildt JV; Loimaala AJ; Hippeläinen ET; Ahonen AA
Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):293-298. PubMed ID: 28950301
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
12. [Left ventricular systolic synchrony assessed by phase analysis of gated myocardial perfusion imaging in patients with old myocardial infarction].
Wang J; Wang Y; Zhang X; Zhou R; Niu R; Lu P
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Jul; 43(7):599-604. PubMed ID: 26420320
[TBL] [Abstract][Full Text] [Related]
13. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of serial quantitative evaluation of
Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
[TBL] [Abstract][Full Text] [Related]
15. Reference values for left ventricular systolic synchrony according to phase analysis of ECG-gated myocardial perfusion SPECT.
Hämäläinen H; Hedman M; Laitinen T; Hedman A; Kivelä A; Laitinen T
Clin Physiol Funct Imaging; 2018 Jan; 38(1):38-45. PubMed ID: 27453042
[TBL] [Abstract][Full Text] [Related]
16. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
[TBL] [Abstract][Full Text] [Related]
17. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
Manabe O; Ohira H; Yoshinaga K; Sato T; Klaipetch A; Oyama-Manabe N; Ito YM; Tsujino I; Nishimura M; Tamaki N
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1558-66. PubMed ID: 23715906
[TBL] [Abstract][Full Text] [Related]
18. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
19. Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.
Raja S; Mittal BR; Santhosh S; Bhattacharya A; Rohit MK
Nucl Med Commun; 2014 Nov; 35(11):1156-61. PubMed ID: 25144559
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Left Ventricular Dyssynchrony Assessed with Nuclear Cardiology in Patients with Known or Suspected Stable Coronary Artery Disease with Preserved Left Ventricular Ejection Fraction.
Hatta T; Yoda S; Hayase M; Monno K; Hori Y; Fujito H; Suzuki Y; Matsumoto N; Okumura Y
Int Heart J; 2020 Jul; 61(4):685-694. PubMed ID: 32684598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
